Cargando…
Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model
Cancer metastases arise in part from disseminated tumor cells originating from the primary tumor and from residual disease persisting after therapy. The identification of biomarkers on micro-metastases, disseminated tumors, and residual disease may yield novel tools for early detection and treatment...
Autores principales: | Franci, Christian, Zhou, Jenny, Jiang, Zhaoshi, Modrusan, Zora, Good, Zinaida, Jackson, Erica, Kouros-Mehr, Hosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592916/ https://www.ncbi.nlm.nih.gov/pubmed/23520493 http://dx.doi.org/10.1371/journal.pone.0058183 |
Ejemplares similares
-
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
por: Cai, Ying, et al.
Publicado: (2017) -
MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model
por: Kwa, Mei Qi, et al.
Publicado: (2021) -
A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice
por: Mohammad Mirzaei, Navid, et al.
Publicado: (2022) -
Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model
por: Roselli, Séverine, et al.
Publicado: (2014) -
Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer
por: Velazquez, Fabiola N., et al.
Publicado: (2021)